Inventor
RODRIGUEZ MARTHA E
US18 patents
⚠️ This page may combine multiple inventors who share the name “RODRIGUEZ MARTHA E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
6 patentsUS6586467B2Jul 1, 2003
Preparation of phosphatase inhibitors
ARRAY BIOPHARMA INC11 citations73
US11634417B2Apr 25, 2023
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC2 citations70
US9809590B2Nov 7, 2017
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC1 citations61
US11884664B2Jan 30, 2024
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC0 citations59
US10669269B2Jun 2, 2020
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC0 citations49
US12187721B2Jan 7, 2025
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC0 citations47
MIRATI THERAPEUTICS INC
5 patentsUS10125134B2Nov 13, 2018
KRas G12C inhibitors
MIRATI THERAPEUTICS INC43 citations96
US10689377B2Jun 23, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC16 citations85
US11453683B1Sep 27, 2022
KRas G12D inhibitors
MIRATI THERAPEUTICS INC13 citations83
US10633381B2Apr 28, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC8 citations82
US11964989B2Apr 23, 2024
KRas G12D inhibitors
MIRATI THERAPEUTICS INC2 citations71
BOYS MARK LAURENCE
2 patentsUS9174981B2Nov 3, 2015
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
BOYS MARK LAURENCE3 citations58
US8841455B2Sep 23, 2014
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
BOYS MARK LAURENCE1 citations46